My Tiny Feed

faz.net

BC 007 Fails Long Covid Trial, Subsidiary Files for Insolvency

A clinical trial for the Long Covid drug BC 007 showed negative results, leading to the insolvency of the drug's German subsidiary.

Read original article in German

German

Germany

HealthGermany HealthcareInsolvencyLong CovidPharmaceuticalDrug Trial

Berlin CuresCharité

Carmen Scheibenbogen

What were the findings regarding the safety and tolerability of BC 007?: Berlin Cures stated that while BC 007 showed no evidence of being better than a placebo for Long Covid, it did prove safe and well-tolerated. Further analyses have not yet been conducted.
What were the results of the study on the drug BC 007 for treating Long Covid?: The drug BC 007, initially showing promise for treating Long Covid, failed to demonstrate superiority over a placebo in a study. The manufacturer, Berlin Cures, announced the negative results, and its German subsidiary has filed for insolvency.
What were the early reports about the effectiveness of BC 007 and why were they limited?: Early reports of BC 007's efficacy were based on a single successful case, which is insufficient to draw definitive conclusions. The drug also underwent Phase II trials for heart failure.
What are the broader implications of the BC 007 failure and the insolvency of the German subsidiary?: The failure of BC 007, coupled with the insolvency of its German subsidiary, highlights the challenges in developing effective treatments for Long Covid and the risks involved in pharmaceutical research.
What is the implication of the negative study results regarding the role of autoantibodies in Long Covid?: The negative study results do not rule out the involvement of autoantibodies in Long Covid, according to immunologist Carmen Scheibenbogen. She notes that the lack of efficacy for BC 007 does not negate the potential role of autoantibodies in the disease.

Jan 22, 10:07

Hessen School Principals Face High Burnout Rates Amidst Teacher Shortage

A survey in Hessen, Germany, reveals that 62 percent of school principals show burnout symptoms due to high workloads stemming from teacher shortages (1,116 unfilled positions) and 229 unfilled principal positions, impacting 13 percent of schools.

Jan 22, 13:11

Bavarian School Principals Face High Burnout Rates Amidst Teacher Shortage

A recent survey of 700 Bavarian school principals by the GEW union revealed that 80% work at a high pace all day, 70% rarely take breaks, and burnout is significantly higher than in other professions due to the existing teacher shortage and the lack of support systems.

Jan 21, 19:10

German Health Insurance Contributions Projected to Rise Significantly

The IGES Institute forecasts a substantial rise in German health insurance contributions, reaching 18.5% by 2029 and potentially over 22% by 2035 due to rising healthcare costs and an aging population, prompting the DAK health insurance fund to threaten legal action if reforms aren't implemented.

Jan 21, 13:09

Schleswig-Holstein SPD Proposes Nitrous Oxide Sales Ban for Minors

The SPD in Schleswig-Holstein is proposing a ban on selling nitrous oxide to minors due to its increasing recreational use and associated health risks, mirroring Hamburg's successful pre-existing ban, while awaiting potentially delayed federal action.